137 related articles for article (PubMed ID: 37106286)
41. Primary NTRK-rearranged spindle cell neoplasm of bone harboring an HMBOX1::NTRK3 gene fusion.
Wang Z; Wang J
Genes Chromosomes Cancer; 2023 Aug; 62(8):477-482. PubMed ID: 36740981
[TBL] [Abstract][Full Text] [Related]
42. A Case of Inv(1)(q23q31)
Rekhi B; Shetty O; Bapat P; Gurav M; Qureshi S
Int J Surg Pathol; 2021 Feb; 29(1):102-108. PubMed ID: 32489127
[TBL] [Abstract][Full Text] [Related]
43. Screening for NTRK-rearranged Tumors Using Immunohistochemistry: Comparison of 2 Different pan-TRK Clones in Melanoma Samples.
Bourhis A; Redoulez G; Quintin-Roué I; Marcorelles P; Uguen A
Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):194-196. PubMed ID: 30920961
[TBL] [Abstract][Full Text] [Related]
44.
Siozopoulou V; Marcq E; De Winne K; Norga K; Schmitz G; Duwel V; Delvenne P; Smits E; Pauwels P
Pathol Oncol Res; 2022; 28():1610423. PubMed ID: 35645621
[TBL] [Abstract][Full Text] [Related]
45. Primary NTRK-rearranged Spindle Cell Neoplasm of the Lung: A Clinicopathologic and Molecular Analysis of 3 Cases.
Zhu P; Wang J
Am J Surg Pathol; 2022 Jul; 46(7):1007-1013. PubMed ID: 35220354
[TBL] [Abstract][Full Text] [Related]
46. NTRK gene alterations were enriched in hepatoid or enteroblastic differentiation type of gastric cancer.
Pu X; Fu Y; Sun Q; Li L; Kwasi A; Ma Z; Fan X; Sun B
J Clin Pathol; 2023 Jul; ():. PubMed ID: 37451841
[TBL] [Abstract][Full Text] [Related]
47. TRK Protein Expression in Merkel Cell Carcinoma Is Not Caused by
Cappellesso R; Nicolè L; Del Fiore P; Barzon L; Sinigaglia A; Riccetti S; Franco R; Zito Marino F; Munari G; Zamuner C; Cavallin F; Sbaraglia M; Galuppini F; Bassetto F; Alaibac M; Chiarion-Sileni V; Piccin L; Benna C; Fassan M; Mocellin S; Dei Tos AP
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499693
[TBL] [Abstract][Full Text] [Related]
48.
Pekova B; Sykorova V; Mastnikova K; Vaclavikova E; Moravcova J; Vlcek P; Lastuvka P; Taudy M; Katra R; Bavor P; Kodetova D; Chovanec M; Drozenova J; Astl J; Hrabal P; Vcelak J; Bendlova B
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33923728
[TBL] [Abstract][Full Text] [Related]
49. Identifying patients with NTRK fusion cancer.
Solomon JP; Benayed R; Hechtman JF; Ladanyi M
Ann Oncol; 2019 Nov; 30(Suppl_8):viii16-viii22. PubMed ID: 31738428
[TBL] [Abstract][Full Text] [Related]
50. Limited Accuracy of Pan-Trk Immunohistochemistry Screening for
Macerola E; Proietti A; Poma AM; Vignali P; Sparavelli R; Ginori A; Basolo A; Elisei R; Santini F; Basolo F
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806472
[TBL] [Abstract][Full Text] [Related]
51. NTRK fusion analysis reveals enrichment in Middle Eastern BRAF wild-type PTC.
Kong Y; Bu R; Parvathareddy SK; Siraj AK; Siraj N; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Eur J Endocrinol; 2021 Apr; 184(4):503-511. PubMed ID: 33524004
[TBL] [Abstract][Full Text] [Related]
52. The Pan-TRK Antibody is a Sensitive and Specific Tool for the Detection of NTRK Fusion Genes.
Bautista-Wong C; Mojica-González Z; Hop-Garcia K; Bornstein Quevedo L
Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):213-216. PubMed ID: 37017998
[TBL] [Abstract][Full Text] [Related]
53. Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy.
Hsiao SJ; Zehir A; Sireci AN; Aisner DL
J Mol Diagn; 2019 Jul; 21(4):553-571. PubMed ID: 31075511
[TBL] [Abstract][Full Text] [Related]
54. Myxoid Spindle Cell Sarcoma With
So YK; Chow C; To KF; Chan JKC; Cheuk W
Int J Surg Pathol; 2020 Aug; 28(5):574-578. PubMed ID: 32050835
[TBL] [Abstract][Full Text] [Related]
55. NTRK fusions and Trk proteins: what are they and how to test for them.
Weiss LM; Funari VA
Hum Pathol; 2021 Jun; 112():59-69. PubMed ID: 33794242
[TBL] [Abstract][Full Text] [Related]
56. [Correlation of NTRK genetic fusions with mismatch repair protein deletion in patients with colorectal cancer].
Pu XH; Gao FP; Wu HY; Fu Y; Fan XS
Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):103-107. PubMed ID: 35152627
[No Abstract] [Full Text] [Related]
57. NTRK fusion in Japanese colorectal adenocarcinomas.
Yamashiro Y; Kurihara T; Hayashi T; Suehara Y; Yao T; Kato S; Saito T
Sci Rep; 2021 Mar; 11(1):5635. PubMed ID: 33707574
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value and characterization of NTRK1 variation by fluorescence in situ hybridization in esophageal squamous cell carcinoma.
Yu Z; Wang H; Song Q; Huang J; Xu J; Su J; Wang H; Tan L; Wang X; Jiang Z; Chen W; Jiang D; Hou Y
J Cancer Res Clin Oncol; 2021 Oct; 147(10):3113-3121. PubMed ID: 33963905
[TBL] [Abstract][Full Text] [Related]
59. NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line.
Lee SJ; Li GG; Kim ST; Hong ME; Jang J; Yoon N; Ahn SM; Murphy D; Christiansen J; Wei G; Hornby Z; Lee DW; Park JO; Park YS; Lim HY; Hong SN; Kim SH; Kang WK; Park K; Park WY; Kim KM; Lee J
Oncotarget; 2015 Nov; 6(36):39028-35. PubMed ID: 26472021
[TBL] [Abstract][Full Text] [Related]
60. Chromosomal imbalances detected in NTRK-rearranged sarcomas by the use of comparative genomic hybridisation.
Vargas AC; Ardakani NM; Wong DD; Maclean FM; Kattampallil J; Boyle R; Santos L; Gill AJ
Histopathology; 2021 Jun; 78(7):932-942. PubMed ID: 33128780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]